Back to VRTX

Bellevue Group AG → VRTX

Bellevue Group AG VRTX Position History

Vertex Pharmaceuticals Incorporated • Healthcare

Quarters held
8
Latest value
$291.4M
Q3 2026
Peak value
$302.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.2M
Q4 2025$302.6M
Q1 2026$6.5M
Q1 2026$298M
Q2 2026$10.6M
Q2 2026$276.9M
Q3 2026$11.1M
Q3 2026$291.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$291.4M557.4K——
Q3 2026$11.1M21.2K——
Q2 2026$276.9M557.4K——
Q2 2026$10.6M21.3K——
Q1 2026$298M667.4K——
Q1 2026$6.5M14.5K——
Q4 2025$302.6M667.4K——
Q4 2025$6.2M13.7K——

Other funds holding VRTX

Other Bellevue Group AG positions

RVMDW

REVOLUTION MEDICINES INC

$398.3M
ARGX

ARGENX SE

$386M
IONS

IONIS PHARMACEUTICALS INC

$377.7M
AMGN

AMGEN INC

$350.5M
GILD

GILEAD SCIENCES INC

$312M
AMGN

AMGEN INC

$301.1M
ARGX

ARGENX SE

$279.3M
ARGX

ARGENX SE

$277.9M